Windlas Biotech Limited has informed the Exchange regarding Allotment of 28990 Shares under ESOP Scheme(s)

WINDLAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-6.4%1-day move

₹755.00

prior close

₹720.50

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.2+0.2+0.1-6.4-3.4-2.7-4.6-2.6+0.0+5.2+8.0+0.5+8.6

Up moveDown movePending

AI summary

Windlas Biotech has allotted 28,990 equity shares of face value Rs. 5 each on March 13, 2026, under its Employee Stock Option Plan 2021 (4,115 shares) and WBL Employee Stock Option Scheme 2023 (24,875 shares). This is a routine exercise of employee stock options, resulting in a marginal increase in the company's total outstanding share count. The dilution from this allotment is very small relative to typical share capital bases of listed companies.

Likely market impact

Minor dilution for existing shareholders due to a small share issuance; this is a routine ESOP event and unlikely to materially affect the stock price. Reflects the company honoring its employee incentive commitments.